IDEXX LABORATORIES INC /DE Loss Contingency Accrual
IDEXX LABORATORIES INC /DE (IDXX) had Loss Contingency Accrual of $27.50 million as of 2020-12-31, per its 10-K filed 2021-02-12.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyAccrualAtCarryingValue · last filed 2024-05-01
- 2020-12-31: Loss Contingency Accrual $27.50M.
- 2020-09-30: Loss Contingency Accrual $27.50M.
| Period end | Loss Contingency Accrual |
|---|---|
| 2020-12-31 | $27.50M 10-K · filed 2021-02-12 |
| 2020-09-30 | $27.50M 10-Q · filed 2024-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |